Key insights
- Kingboard Holdings, a Hong Kong-based supplier of laminates and circuit boards, surged over 20% following news of a significant stake sale in its laminate subsidiary and a 15% product price hike. This move, driven by strong AI demand and rising costs, highlights robust activity in the AI supply chain. While the direct impact on US equities is moderate, it signals continued strength and potential investment opportunities within the broader AI ecosystem, which has significant spillover effects.

Investing.com — The AI rally keeps finding new ground to cover. After weeks of gains in chips and hardware, the same momentum is now ripping through materials suppliers and beyond.
While InvestingPro members have been riding the hardware wave all month with early calls on names like Veeco (NASDAQGS:VECO) up +31.35% and Marvell Technology (MRVL) up +27.00%, the standout story over the past 24 hours belongs to a name further down the AI supply chain.
Just this morning, one Hong Kong-based supplier of laminates, circuit boards, and chemicals surged 20.5% in a single session, extending its June run to nearly 94% — and members who received our monthly-updated list of stock picks for LESS THAN $7 a month were positioned in it well before this huge rally.
Here are just a few of June’s other standout performers so far:
And the gains stretch well beyond Wall Street. Across our global strategies, the numbers are even bigger:
Want to see the full list? InvestingPro members can access the list of stock picks for June HERE.
Still not a member? Then here’s your chance to get the full list of picks NOW:
So which stock exploded today?
That stock was Kingboard Holdings (SEHK:148). The company jumped a massive 20.5% today to reach HK$119.3, after it unveiled two big pieces of news: a large-scale stake sale in its laminate subsidiary and a fresh round of product price hikes that underpin just how strong demand for its AI-supporting materials business has become.
Kingboard’s wholly-owned subsidiary, Kingboard Investment, agreed to sell roughly 155 million shares of Kingboard Laminates at HK$76.0 per share, generating net proceeds of approximately HK$11.77 billion ($1.5 billion) — capital management says will be redeployed into expanding PCB production capacity and accelerating R&D. The move came alongside the fifth product price increase of the year, lifting prices across all FR-4 and PP products by 15% on persistently high copper costs and tightening glass cloth supply.
The stock is now up +93.86% in June ALONE and has extended its gains to an eye-watering +486.36% since being selected in February last year, with shares nearly tripling in 2026 alone as demand for chipmaking and circuit board materials accelerates across the global AI buildout.
Closer to home, one of our US healthcare picks delivered its own run of news that backs up exactly why ProPicks AI caught it first.
The news behind Amneal Pharmaceuticals (NASDAQGS:AMRX)
Amneal recently secured FDA approval for its ready-to-use romidepsin cancer therapy, with six months of market exclusivity giving the company another differentiated launch with limited near-term generic competition.
Separately, full-population results from the ELEVATE-PD study reinforced CREXONT’s ability to deliver meaningful clinical benefits for Parkinson’s patients in real-world settings, supporting its ongoing commercial rollout.
Both developments build directly on the growth story our models identified at the start of the month.
What our models flagged in Amneal before the rally
By applying investor-grade financial research and machine-learning models to more than 60,000 stocks worldwide, ProPicks AI finds the companies where fundamentals and growth outlook point to outsized moves before the broader market catches on. Every pick comes with the rationale behind it, so members know exactly what the data showed at the time.
Want to see the full list? InvestingPro members can access June’s complete set of AI-powered stock picks HERE.
Here is what our ML engine identified in Amneal Pharmaceuticals before its June run:
The FDA approval and ELEVATE-PD results are simply the latest proof points building on a thesis the data had already made clear.
A track record built on getting there first
Amneal’s run is just one piece of a much longer compounding story. Here are some of the gains members are currently sitting on since their stocks were first selected:
Since launch in November 2023, that same disciplined process has compounded into an enormous +227.24% return, outpacing the S&P 500 by an extraordinary +150.15%.
These are real-world numbers, recorded since the official launch of our AI models in November 2023.
InvestingPro members can access the list of stock picks for June HERE.
Still not a member? Then here’s your chance to get the full list of picks NOW:
How Investing.com’s AI-Powered Stock Picker Works
At the beginning of each month, our proprietary AI system evaluates thousands of global equities using a complex blend of historical data, valuation signals, and forward-looking growth metrics.
By processing more than 15 years of financial data across more than 150 quantitative models, the engine identifies up to 20 high-conviction stocks per strategy based on their projected medium-term upside potential.
Every month, these strategies undergo a strict rebalancing process. New opportunities are added, strong performers are retained, and stocks that no longer meet the criteria are removed.
To consistently track performance, each strategy utilises equal weighting across all selected stocks. While investors are free to adjust their own allocations, this structure provides a transparent benchmark for evaluating overall model performance.
The goal is to keep capital positioned in the companies showing the strongest combination of momentum, valuation, and business performance.
Disclaimer: Subscription prices mentioned in articles are accurate at the time of publication. We regularly test different offers for our members, which may vary by region.
Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.